352770 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Clinomics, Inc. engages in the development and commercialization of cancer and disease early diagnosis technology services. Its products and services include COVID-19 test kits, liquid biopsy and precision medicine, health care, and big data. The company was founded on June 21, 2011 and is headquartered in Ulsan, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
352770 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company